Government to ease BA-BE study norms for domestic generic drug approvals, cut import licence timelines

Pharmaceutical companies will soon find it easier to conduct drug studies. Applicants can start eligible trials after intimating the drug regulator. This change aims to speed up the launch of generic drugs locally. Import licence applications for new drugs will also see reduced processing times. These measures are part of efforts to improve ease of doing business.